0001209191-15-079468.txt : 20151111 0001209191-15-079468.hdr.sgml : 20151111 20151110213819 ACCESSION NUMBER: 0001209191-15-079468 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151106 FILED AS OF DATE: 20151110 DATE AS OF CHANGE: 20151110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KINGSLEY ALFRED D CENTRAL INDEX KEY: 0001229339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 151220937 MAIL ADDRESS: STREET 1: 150 E 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-11-06 0 0000876343 BIOTIME INC BTX 0001229339 KINGSLEY ALFRED D 150 E. 57TH STREET NEW YORK NY 10022 1 1 1 0 See Remarks Common Shares, no par value 2015-11-06 4 S 0 100000 3.83 D 5938055 D Common Shares, no par value 1506905 I By Greenbelt Corp. Common Shares, no par value 375351 I By Greenway Partners, LP Option to Purchase Common Shares 3.57 2020-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 3.11 2019-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 4.13 2018-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 4.60 2017-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 5.13 2016-06-30 Common Shares 50000 50000 D The securities were sold in a private transaction. Mr. Kingsley plans to invest the sale proceeds in Ascendance Biotechnology, Inc., a new subsidiary of BioTime. Does not include shares that Mr. Kingsley may acquire through the exercise of certain options. 12,500 options became exercisable on September 30, 2015 and the remaining 37,500 options will become exercisable in 3 equal quarterly installments based upon continued service on the board of directors. 12,500 options became exercisable on September 30, 2014; December 31, 2014; March 31, 2015; and June 30, 2015. 12,500 options became exercisable on September 30, 2013; December 31, 2013; March 31, 2014; and June 30, 2014. 12,500 options became exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013. 12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012. Mr. Kingsley is Executive Chairman of certain BioTime subsidiaries. /s/ Alfred D. Kingsley 2015-11-10